Vaccinex News - VCNX

Company Name	Stock Ticker Symbol	Market	Type
Vaccinex Inc	VCNX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	4.94	04:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				4.94

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/02/2024	08:30	GLOBE	Vaccinex Reports 2023 Financial Results and Provides..
3/27/2024	08:30	GLOBE	Vaccinex, Inc. Announces $1.5 Million Registered Direct..
3/04/2024	16:19	EDGAR2	Form 8-K - Current report
2/21/2024	10:10	EDGAR2	Form 8-K - Current report
2/21/2024	08:00	GLOBE	Vaccinex Announces Multiple New Agreements for Access to..
2/15/2024	08:06	EDGAR2	Form 8-K - Current report
2/15/2024	08:00	GLOBE	Vaccinex, Inc. Announces Reverse Stock Split
2/13/2024	16:30	EDGAR2	Form 8-K - Current report
2/13/2024	16:15	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/12/2024	16:22	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/09/2024	16:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/09/2024	16:08	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/08/2024	08:20	EDGAR2	Form 8-K/A - Current report: [Amend]
2/07/2024	15:43	EDGAR2	Form 8-K - Current report
2/07/2024	08:00	GLOBE	Vaccinex Announces Pricing of $3.7 Million PIPE Financing
1/22/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/19/2024	16:40	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/10/2024	17:16	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/08/2024	16:16	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/28/2023	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/28/2023	16:15	EDGAR2	Form PRE 14A - Other preliminary proxy statements
12/12/2023	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/04/2023	08:00	GLOBE	Nasdaq Grants Vaccinex Extension Until March 4, 2024 to..
11/13/2023	08:00	GLOBE	Vaccinex Reports Third Quarter 2023 Financial Results and..
11/13/2023	07:46	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/2023	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/31/2023	09:00	GLOBE	Vaccinex Reports Clinical Benefit in Interim Analyses from..
10/26/2023	09:30	EDGAR2	Form 8-K - Current report
10/26/2023	09:30	GLOBE	Vaccinex Reports Positive Effect of Pepinemab Treatment on..
10/25/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/18/2023	16:15	EDGAR2	Form SC 13D/A - General statement of acquisition of..
10/13/2023	16:54	EDGAR2	Form 8-K - Current report
10/12/2023	16:30	EDGAR2	Form SC 13D/A - General statement of acquisition of..
10/05/2023	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/05/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/05/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	09:20	EDGAR2	Form 8-K - Current report
10/02/2023	09:16	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
9/28/2023	20:41	EDGAR2	Form S-1MEF - Registration adding securities to prior Form..
9/27/2023	08:00	EDGAR2	Form 8-K - Current report
9/26/2023	16:15	EDGAR2	Form SC 13D/A - General statement of acquisition of..
9/26/2023	08:06	EDGAR2	Form 8-K - Current report
9/26/2023	08:01	EDGAR2	Form S-1/A - General form for registration of securities..
9/25/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/22/2023	16:37	EDGAR2	Form 8-K - Current report
9/22/2023	16:21	EDGAR2	Form 8-K - Current report
9/14/2023	17:26	EDGAR2	Form S-1 - General form for registration of securities under..
9/13/2023	06:46	EDGAR2	Form 8-K - Current report
8/22/2023	16:31	EDGAR2	Form 8-K - Current report